Our Chief Business Officer Savita Bernal attended HYBRID 2021, on March 16th, an event focused this year on Immunology and Inflammatory Disorders. Savita shared with the audience a presentation entitled « Diversity Matters : MaaT Pharma’s Microbiome Ecosystem Therapies in Graft-vs-Host-Disease and Oncology».
See the full video down below.
